General Information |
| Clinical trials phase |
Phase 1 |
| Start date (estimated) |
2023-12-22 |
| Clinical feature |
| Label |
Parkinson's disease |
| Link |
http://purl.obolibrary.org/obo/DOID_14330 |
| Description |
A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions.; Xref MGI.
OMIM mapping confirmed by DO. [SN]. |
|
Administrative Information |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT20160704028786N2 |
| Other study identifiers |
| Name |
IRCT20160704028786N2 |
| Description |
(IRCT registration number) |
|
| Source weblink |
https://en.irct.ir/trial/71062 |
| Public contact |
| Email |
salahi13639@gmail.com |
| Public email |
salahi13639@gmail.com |
| First name |
Sarvenaz |
| Last name |
Salahi |
| Phone |
+98 21 2356 2000 |
| Country |
|
|
| Sponsors |
Iranian academic center for education culture and research
Shiraz University of Medical Sciences
Iran University of Medical Sciences
|
Cells |
| Which differentiated cell type is used |
| Label |
dopaminergic neuron |
| Link |
http://purl.obolibrary.org/obo/CL_0000700 |
| Description |
A neuron that releases dopamine as a neurotransmitter. |
|
Recruitment |
| Recruitment Status |
Unknown Status |
| Comment recruitment status |
Pending |
| Estimated number of participants |
4 |
